Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An Open-Label Pharmacokinetic and Pharmacodynamic Study of a Single Dose of IDN-6556 in Subjects With Hepatic Impairment and in Matched Healthy Volunteers

Next Previous
X
Search
Trial Profile

An Open-Label Pharmacokinetic and Pharmacodynamic Study of a Single Dose of IDN-6556 in Subjects With Hepatic Impairment and in Matched Healthy Volunteers

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 06 Nov 2021

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Emricasan (Primary)
  • Indications Alcoholic hepatitis; Hepatic fibrosis; Liver failure; Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Type 1 diabetes mellitus
  • Focus Pharmacokinetics
  • Sponsors Conatus Pharmaceuticals

    • Most Recent Events

    • 08 Apr 2015 According to a Conatus Pharmaceuticals media release, results will be presented at The International Liver Congress™ 2015, the 50th Annual Meeting of the European Association for the Study of the Liver (EASL).
    • 11 Mar 2015 According to a Conatus Pharmaceuticals media release, aggregate top-line results from this and two other (phase I and phase IIb) trials (n=73) in five distinct organ impairment patient populations were released in Jan 2015.
    • 22 Dec 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top